News
![Medical vials and Syringe, Isolated on Blue background](https://pharmaphorum.com/wp-content/uploads/2018/05/iStock-497966534.jpg)
Civica plans shake-up of insulin sector with low-cost biosim...
Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.